Interpace Biosciences (OTCMKTS:IDXG) Stock Breaks Above Fifty Day Moving Average – Here’s What Happened

Interpace Biosciences, Inc. (OTCMKTS:IDXG) shares passed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $6.64 and traded as high as $7.45. Interpace Biosciences shares last traded at $7.00, with a volume of 2,110 shares trading hands.

Interpace Biosciences Stock Performance

The company’s 50-day moving average price is $6.63 and its two-hundred day moving average price is $8.02.

Interpace Biosciences (OTCMKTS:IDXG) last announced its quarterly earnings data on Monday, August 10th. The business services provider reported $0.05 earnings per share for the quarter. Interpace Biosciences had a return on equity of 145.40% and a net margin of 67.64%. The firm had revenue of $9.13 million during the quarter.

Interpace Biosciences Company Profile

Interpace Biosciences, Inc is a molecular diagnostics company focused on improving the diagnosis and management of cancer and other complex diseases. The company develops and commercializes molecular tests that help physicians evaluate disease risk, guide treatment decisions and reduce uncertainty associated with conventional diagnostic procedures.

Its portfolio has included tests for thyroid, pancreatic and gastroesophageal conditions. ThyGeNEXT and ThyraMIR are designed to help evaluate indeterminate thyroid nodules, while PancraGEN supports risk assessment for pancreatic cysts.